Sackner-Bernstein Jonathan 4
4 · NeoStem, Inc. · Filed Apr 4, 2012
Insider Transaction Report
Form 4
Sackner-Bernstein Jonathan
VP Clinical Dev & Reg Affairs
Transactions
- Award
Stock Option (right to purchase)
2012-04-02+400,000→ 400,000 totalExercise: $0.38Exp: 2022-04-01→ Common Stock (400,000 underlying)
Footnotes (1)
- [F1]On April 2, 2012, the commencement date (the "Commencement Date") of his employment with NeoStem, Inc. (the "Company"), the Reporting Person was granted an option to purchase 400,000 shares of the Company's common stock, par value $0.001 per share (the "Common Stock"), pursuant and subject to the terms and conditions of the Company's 2009 Equity Compensation Plan. This option shall vest as to 100,000 shares on each of December 31, 2012, April 2, 2013, April 2, 2014, and April 2, 2015, provided that the Reporting Person remains employed by the Company on each of such dates.